A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nuvalent, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 61,700 shares of NUVL stock, worth $5.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,700
Previous 72,800 15.25%
Holding current value
$5.52 Million
Previous $5.47 Million 14.38%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$62.76 - $81.61 $6.53 Million - $8.5 Million
-104,100 Reduced 94.74%
5,784 $438,000
Q1 2024

May 15, 2024

SELL
$72.35 - $88.99 $7.18 Million - $8.83 Million
-99,257 Reduced 47.46%
109,884 $8.25 Million
Q4 2023

Feb 14, 2024

BUY
$42.42 - $80.28 $8.86 Million - $16.8 Million
208,934 Added 100934.3%
209,141 $15.4 Million
Q3 2023

Nov 14, 2023

SELL
$39.12 - $49.85 $1.76 Million - $2.24 Million
-44,963 Reduced 99.54%
207 $9,000
Q2 2023

Aug 14, 2023

BUY
$23.58 - $44.68 $460,423 - $872,421
19,526 Added 76.14%
45,170 $1.9 Million
Q1 2023

May 15, 2023

BUY
$25.42 - $33.52 $645,922 - $851,743
25,410 Added 10858.97%
25,644 $669,000
Q4 2022

Feb 14, 2023

SELL
$18.46 - $36.37 $742,664 - $1.46 Million
-40,231 Reduced 99.42%
234 $6,000
Q3 2022

Nov 14, 2022

SELL
$13.55 - $19.92 $708,624 - $1.04 Million
-52,297 Reduced 56.38%
40,465 $787,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.85B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.